|
C反应蛋白及其多态性与冠心病 |
|
;in the West of Scotland Coronary Prevention Study[J]. Diabetes, 2002,51:15961600.
[14] SATTAR N, MCCONNACHIE A, O’REILLY D, et al. Inverse association between birthweight and Creactive protein concentrations in the MIDSPAN family study[J]. Arterioscler Thromb Vasc Biol,2004,24:583587.
[15] PANKOW JS, FOLSOM AR, CUSHMAN M,et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study[J]. Atherosclerosis, 2001,154:681689.
[16] DUPUIS J, LARSON MG, VASAN RS, et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q[J]. Atherosclerosis, 2005,182: 307314.
[17] CRAWFORD DC, YI Q, SMITH JD, et al. Allelic spectrum of natural variation in CRP[J].Hum Genet,2006,119:496504.
[18] CASAS JP,SHAH T, COOPER J,et al.Insight into the nature of the CRPcoronary event association using Mendelian randomization[J].Int J Epidemiol, 2006,35:922931.
[19] KATHIRESAN S, LARSON MG, VASAN RS, et al.Contribution of clinical correlates and 13 Creactive protein gene polymorphisms to interindividual variability in Serum CReactive Protein Level[J].Circulation,2006,113:14151423.
[上一页 [1] [2] [3] [4] [5] [6] [7] 下一页 上一个医学论文: 血小板膜GP b 基因多态性与血栓性疾病相关性的研究进展 下一个医学论文: CD 40 CD 40L与血栓性疾病研究进展
|
|
|